CRL

CRL N/A N/A

Back to Search

$0.00

+$0.00 (+0.00%)

Open: $0.00 | High: $0.00 | Low: $0.00 | Prev Close: $0.00

Market Cap: N/A

Volume: N/A | Avg: N/A

Last updated: January 27, 2026 at 07:19 AM
Featured In

This stock appears in the following dashboards:

Options Activity
Featured
Unusual Options
Featured
Options Screener
Featured
Options Activity for CRL
Options Screener Data
Type Strike Expiration Premium Premium Yield Call Vol Put Vol P/C Ratio Rating
N/A $N/A N/A $N/A N/A% N/A N/A N/A N/A/10
View Full Options Screener
Puts/Calls Activity
Type Strike Expiration Premium Volume ROI % Breakeven Delta
N/A $N/A N/A $N/A N/A N/A% $N/A N/A
View Full Options Activity
Investment Rating
N/A

No score available for this stock

Overall Score: 0/100

Rating Breakdown:
DCF Score 0/5
0%
N/A
ROE Score 0/5
0%
N/A
ROA Score 0/5
0%
N/A
D/E Score 0/5
0%
N/A
P/E Score 0/5
0%
N/A
P/B Score 0/5
0%
N/A
Add to Watchlist Add to Portfolio
Stock Score Analysis
E

Stock Score: 330

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 0
Financial Health 30
Growth 0
Market Sentiment 0
Risk 0
Lower is better
Valuation 0
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio
P/B Ratio
P/S Ratio
EPS $
Beta
Shares Outstanding N/A
Price Range & Moving Averages
52-Week High $
52-Week Low $
SMA 50 $
SMA 200 $
Financial Ratios
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Returns
ROE 0.0%
ROA 0.0%
Liquidity & Leverage
Debt/Equity
Current Ratio
Quick Ratio
Balance Sheet
Total Assets N/A
Total Liabilities N/A
Total Equity N/A
Cash N/A
Total Debt N/A
Net Debt N/A
Income Statement
Revenue N/A
Gross Profit N/A
Operating Income N/A
Net Income N/A
EBITDA N/A
Revenue/Share $
Cash Flow
Operating CF N/A
CapEx N/A
Free Cash Flow N/A
Book Value/Share $
Tangible Book/Share $
Equity/Share $
Technical Indicators
RSI (14) 50.00 Neutral
MACD
0.00 Signal: 0.00
Volatility 0.00%
Trading Signal Neutral
Performance & Returns

Insufficient historical data

Insufficient historical data (need 200+ days, have 32)
Sector Comparison

Sector comparison unavailable

No sector data available
📊 Historical Price Analysis (Last 200 Days)

Loading chart...

Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
CRL $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 50.00 0.00 0.00% 0 Neutral Mixed
Candlestick Patterns

There wasn't any recognizable pattern for the CRL stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
CRL Charles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Neutral seekingalpha.com Read More
CRL Cresset Asset Management LLC Has $1.36 Million Stock Position in Charles River Laboratories International, Inc. $CRL Neutral defenseworld.net Read More
CRL Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript Neutral seekingalpha.com Read More
CRL Charles River Laboratories to Present at TD Cowen and Barclays Conferences Neutral businesswire.com Read More
CRL Charles River raises annual profit view as it sells underperforming assets Positive reuters.com Read More
Recent Insider Trading
Date Insider Position Transaction Shares Price Value
2026-03-02 FOSTER JAMES C director, officer: Chairman, President and CEO BUY 16796 $178.61 $2999934
Showing last 10 insider transactions. Green badges indicate purchases (bullish signal), red badges indicate sales.
Company Information

CRL is a company in the N/A sector.

CEO N/A
Employees
Country N/A
IPO Date N/A
Exchange N/A
Sector N/A
Industry N/A
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.